References
Nottingham Trent University | ||
|---|---|---|
| People |  | |
| Schools |
| |
| Research | ||
| Student life | ||
| Affiliates | ||
| Other | ||
| Formation | 2008 |
|---|---|
| Type | University research centre |
| Focus | Cancer research |
| Headquarters | Nottingham, England |
Director | Sergio Rutella |
| Affiliations | Nottingham Trent University |
| Website | https://www.ntu.ac.uk/research/john-van-geest-cancer-research-centre |
The John van Geest Cancer Research Centre is a cancer research institute based at Nottingham Trent University in Nottingham, England. The centre conducts research into the diagnosis, prognosis and treatment of cancer, with a particular focus on cancer immunotherapy, tumour biology and personalised medicine. [1]
The centre is located within the university’s School of Science and Technology and contributes to NTU’s health and biomedical research activity.
The John van Geest Cancer Research Centre was established in 2008 with an initial donation of £7.5 million from the John and Lucille van Geest Foundation, which has funded medical research since the 1970s. [2]
In 2013, the centre received a further donation of almost £8 million from the foundation to support research into the early diagnosis and treatment of cancer, including work on cancer immunisation and vaccination approaches. [2] By that point, total donations from the foundation to support cancer research at Nottingham Trent University exceeded £16 million. [2]
Research at the John van Geest Cancer Research Centre investigates the molecular and cellular mechanisms underpinning cancer development and progression. Key areas of study include tumour heterogeneity, the tumour microenvironment, and the identification of biomarkers associated with therapeutic response and resistance. [1]
The centre’s work includes research into genomics-guided cancer immunotherapy, cancer vaccines, non-coding RNAs and epigenetic regulation, brain tumour biology, and cancer cell signalling pathways. Its research aims to contribute to improved early diagnosis, personalised treatment strategies and better clinical outcomes for patients with cancer. [1]
The centre is based at Nottingham Trent University’s Clifton Campus and forms part of the university’s Health Innovation research theme. It collaborates with academic departments across NTU as well as with external partners in the United Kingdom and internationally, including universities, hospitals and biotechnology companies. [1]
The centre is directed by Professor Sergio Rutella, a haematologist and cancer immunologist, who oversees its research strategy and collaborations. [1]
In addition to philanthropic funding from the John and Lucille van Geest Foundation, the centre’s research is supported through competitive research grants and collaborative projects. The centre works with academic, clinical and commercial partners in Europe and North America, contributing to translational research and the development of novel cancer therapies. [1]
Nottingham Trent University | ||
|---|---|---|
| People | | |
| Schools |
| |
| Research | ||
| Student life | ||
| Affiliates | ||
| Other | ||